Author:
Li Weizhong,Wang Xiaoyan,Li Zuguo,Ding Yanqing
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Li WZ, Wang XY, Li ZG, et al. Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma in vivo and in vitro. J Oral Pathol Med, 2010, 39: 579–584.
2. Dvory-Sobol H, Arber N. Cyclooxygenase-2 as target for chemopreventive interventions: new approaches. Cancer Biomark, 2007, 3: 153–161.
3. Botting RM. Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927–2004). J Therm Biol, 2006, 31: 208–219.
4. Renkonen J, Wolff H, Paavonen T. Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Arch, 2002, 440: 594–597.
5. Méric JB, Rottey S, Olaussen K, et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol, 2006, 59: 51–64.